The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation

Table 5

Cohorts studied with the lectin ELISA.

Cohort	Abbreviation	Number of samples
Patients with primary APS	PAPS	12
Patients with APS and SLE as underlying disease	SAPS	10
Patients with SLE without symptoms of APS harbouring circulating aPL	SLE + aPL	15
Asymptomatic carriers of aPL	aaPL	6
Healthy children with circulating anti-β2GP1	—	16

APS = antiphospholipid syndrome; aPL = antiphospholipid antibodies; SLE = systemic lupus erythematosus.